1. Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa 
Barbara Spitzer, Miguel-Angel Perales, Nancy A. Kernan, Susan E. Prockop, Emily C. Zabor, Nicholas Webb, Hugo Castro-Malaspina, Esperanza B. Papadopoulos, James W. Young, Andromachi Scaradavou, Rachel Kobos, Sergio A. Giralt, Richard J. O'Reilly, Farid Boulad 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 8, Pages (August 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Overall and disease-free survival curves (A) and cumulative incidence of relapse (B) across all patients.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Overall survival (A) and cumulative incidence of relapse (B) stratified by remission duration of ≤6 months or >6 months, demonstrating significantly improved survival and lower incidence of relapse for patients with remission durations greater than 6 months after their initial allo-HSCT (P < .001).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions